Emily A Bernhardt
Examiner (ID: 12, Phone: (571)272-0664 , Office: P/1624 )
Most Active Art Unit | 1624 |
Art Unit(s) | 1202, 1611, 1621, 1624 |
Total Applications | 3468 |
Issued Applications | 2291 |
Pending Applications | 211 |
Abandoned Applications | 966 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6908324
[patent_doc_number] => 20010011091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-02
[patent_title] => 'Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists'
[patent_app_type] => new
[patent_app_number] => 09/770514
[patent_app_country] => US
[patent_app_date] => 2001-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43043
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0011/20010011091.pdf
[firstpage_image] =>[orig_patent_app_number] => 09770514
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/770514 | Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists | Jan 25, 2001 | Issued |
Array
(
[id] => 6900245
[patent_doc_number] => 20010009921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-07-26
[patent_title] => 'Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists'
[patent_app_type] => new
[patent_app_number] => 09/770513
[patent_app_country] => US
[patent_app_date] => 2001-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44273
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20010009921.pdf
[firstpage_image] =>[orig_patent_app_number] => 09770513
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/770513 | Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists | Jan 25, 2001 | Issued |
Array
(
[id] => 4380085
[patent_doc_number] => 06303602
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-16
[patent_title] => 'Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists'
[patent_app_type] => 1
[patent_app_number] => 9/770512
[patent_app_country] => US
[patent_app_date] => 2001-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47044
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 304
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/303/06303602.pdf
[firstpage_image] =>[orig_patent_app_number] => 770512
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/770512 | Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists | Jan 25, 2001 | Issued |
Array
(
[id] => 6886755
[patent_doc_number] => 20010020024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-09-06
[patent_title] => 'Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists'
[patent_app_type] => new
[patent_app_number] => 09/771030
[patent_app_country] => US
[patent_app_date] => 2001-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46988
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20010020024.pdf
[firstpage_image] =>[orig_patent_app_number] => 09771030
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/771030 | Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists | Jan 25, 2001 | Issued |
Array
(
[id] => 7028746
[patent_doc_number] => 20010014683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-16
[patent_title] => 'Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists'
[patent_app_type] => new
[patent_app_number] => 09/771029
[patent_app_country] => US
[patent_app_date] => 2001-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44546
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20010014683.pdf
[firstpage_image] =>[orig_patent_app_number] => 09771029
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/771029 | Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists | Jan 25, 2001 | Issued |
Array
(
[id] => 4412226
[patent_doc_number] => 06265591
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-24
[patent_title] => 'Process for preparing 4-substituted-1h-indole-3-glyoxamides'
[patent_app_type] => 1
[patent_app_number] => 9/647471
[patent_app_country] => US
[patent_app_date] => 2000-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5521
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/265/06265591.pdf
[firstpage_image] =>[orig_patent_app_number] => 647471
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/647471 | Process for preparing 4-substituted-1h-indole-3-glyoxamides | Sep 26, 2000 | Issued |
Array
(
[id] => 4368357
[patent_doc_number] => 06274590
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-14
[patent_title] => 'Method of treating skin related conditions'
[patent_app_type] => 1
[patent_app_number] => 9/661719
[patent_app_country] => US
[patent_app_date] => 2000-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16476
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/274/06274590.pdf
[firstpage_image] =>[orig_patent_app_number] => 661719
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/661719 | Method of treating skin related conditions | Sep 13, 2000 | Issued |
Array
(
[id] => 4286027
[patent_doc_number] => 06268207
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'Enzymatic resolution of 1-amino-2-vinylcyclopropyl caboxylic acid methyl ester'
[patent_app_type] => 1
[patent_app_number] => 9/660030
[patent_app_country] => US
[patent_app_date] => 2000-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33125
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/268/06268207.pdf
[firstpage_image] =>[orig_patent_app_number] => 660030
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/660030 | Enzymatic resolution of 1-amino-2-vinylcyclopropyl caboxylic acid methyl ester | Sep 11, 2000 | Issued |
Array
(
[id] => 4370644
[patent_doc_number] => 06274740
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-14
[patent_title] => 'Process for the production of amorphous [R-(R*,R*)]-2-(4-fluorophenyl)-.beta., .delta.-dihydroxy-5-(1-methylethy)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)'
[patent_app_type] => 1
[patent_app_number] => 9/657469
[patent_app_country] => US
[patent_app_date] => 2000-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2342
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/274/06274740.pdf
[firstpage_image] =>[orig_patent_app_number] => 657469
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/657469 | Process for the production of amorphous [R-(R*,R*)]-2-(4-fluorophenyl)-.beta., .delta.-dihydroxy-5-(1-methylethy)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) | Sep 6, 2000 | Issued |
Array
(
[id] => 4384224
[patent_doc_number] => 06262101
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-17
[patent_title] => 'Immunotherapeutic agents'
[patent_app_type] => 1
[patent_app_number] => 9/639757
[patent_app_country] => US
[patent_app_date] => 2000-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18081
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 259
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/262/06262101.pdf
[firstpage_image] =>[orig_patent_app_number] => 639757
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/639757 | Immunotherapeutic agents | Aug 15, 2000 | Issued |
Array
(
[id] => 4385084
[patent_doc_number] => 06262151
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-17
[patent_title] => 'Benzotriazole UV absorbers having enhanced durability'
[patent_app_type] => 1
[patent_app_number] => 9/614527
[patent_app_country] => US
[patent_app_date] => 2000-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25330
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1323
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/262/06262151.pdf
[firstpage_image] =>[orig_patent_app_number] => 614527
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/614527 | Benzotriazole UV absorbers having enhanced durability | Jul 11, 2000 | Issued |
09/600016 | HETEROAROMATIC OLIGOAMIDES AS AFFINITY LIGANDS | Jul 10, 2000 | Abandoned |
Array
(
[id] => 4383308
[patent_doc_number] => 06294560
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-25
[patent_title] => 'Synthesis of clasto-lactacystin .beta.-lactone and analogs thereof'
[patent_app_type] => 1
[patent_app_number] => 9/597514
[patent_app_country] => US
[patent_app_date] => 2000-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21474
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/294/06294560.pdf
[firstpage_image] =>[orig_patent_app_number] => 597514
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/597514 | Synthesis of clasto-lactacystin .beta.-lactone and analogs thereof | Jun 19, 2000 | Issued |
Array
(
[id] => 4373656
[patent_doc_number] => 06288241
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-11
[patent_title] => 'Crystalline polymorphic form of 1-methyl-5-p-toluoylpyrrple-2-acetamidoacetic acid guaiacyl ester (MED 15)'
[patent_app_type] => 1
[patent_app_number] => 9/581289
[patent_app_country] => US
[patent_app_date] => 2000-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2497
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/288/06288241.pdf
[firstpage_image] =>[orig_patent_app_number] => 581289
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/581289 | Crystalline polymorphic form of 1-methyl-5-p-toluoylpyrrple-2-acetamidoacetic acid guaiacyl ester (MED 15) | Jun 11, 2000 | Issued |
Array
(
[id] => 4406869
[patent_doc_number] => 06271252
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-07
[patent_title] => 'Cyclic amino acid derivatives as cell adhesion inhibitors'
[patent_app_type] => 1
[patent_app_number] => 9/554989
[patent_app_country] => US
[patent_app_date] => 2000-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17400
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1064
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/271/06271252.pdf
[firstpage_image] =>[orig_patent_app_number] => 554989
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/554989 | Cyclic amino acid derivatives as cell adhesion inhibitors | May 22, 2000 | Issued |
Array
(
[id] => 4408980
[patent_doc_number] => 06232476
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-15
[patent_title] => 'Intermediates in a process for cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy] ethyl}pyrrolidine'
[patent_app_type] => 1
[patent_app_number] => 9/575310
[patent_app_country] => US
[patent_app_date] => 2000-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2430
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/232/06232476.pdf
[firstpage_image] =>[orig_patent_app_number] => 575310
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/575310 | Intermediates in a process for cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy] ethyl}pyrrolidine | May 18, 2000 | Issued |
Array
(
[id] => 4386908
[patent_doc_number] => 06262271
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-17
[patent_title] => 'ISO-CBI and ISO-CI analogs of CC-1065 and the duocarmycins'
[patent_app_type] => 1
[patent_app_number] => 9/529345
[patent_app_country] => US
[patent_app_date] => 2000-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 20
[patent_no_of_words] => 19226
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/262/06262271.pdf
[firstpage_image] =>[orig_patent_app_number] => 529345
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/529345 | ISO-CBI and ISO-CI analogs of CC-1065 and the duocarmycins | Apr 11, 2000 | Issued |
Array
(
[id] => 4274665
[patent_doc_number] => 06323315
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-27
[patent_title] => 'Dolastatin peptides'
[patent_app_type] => 1
[patent_app_number] => 9/539935
[patent_app_country] => US
[patent_app_date] => 2000-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13425
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/323/06323315.pdf
[firstpage_image] =>[orig_patent_app_number] => 539935
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/539935 | Dolastatin peptides | Mar 30, 2000 | Issued |
Array
(
[id] => 4370654
[patent_doc_number] => 06274741
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-14
[patent_title] => 'Process for the preparation of acyl heteroaromatic compounds from heteroaromatic compounds by metal ion exchanged clays'
[patent_app_type] => 1
[patent_app_number] => 9/538095
[patent_app_country] => US
[patent_app_date] => 2000-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2760
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/274/06274741.pdf
[firstpage_image] =>[orig_patent_app_number] => 538095
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/538095 | Process for the preparation of acyl heteroaromatic compounds from heteroaromatic compounds by metal ion exchanged clays | Mar 28, 2000 | Issued |
Array
(
[id] => 4346794
[patent_doc_number] => 06284785
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-04
[patent_title] => '1-arenesulfonyl-2-aryl-pyrrolidine and pyridine derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/534380
[patent_app_country] => US
[patent_app_date] => 2000-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8909
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/284/06284785.pdf
[firstpage_image] =>[orig_patent_app_number] => 534380
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/534380 | 1-arenesulfonyl-2-aryl-pyrrolidine and pyridine derivatives | Mar 23, 2000 | Issued |